Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization

NCT02880605 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT02880605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02880605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Observational
Overall status
Completed
Start date
August 31, 2016
Completion date
October 31, 2018
Enrollment
11,235 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appropriate use criteria, coronary revascularization